» Articles » PMID: 36672009

MiR-15b-5p Expression in the Peripheral Blood: A Potential Diagnostic Biomarker of Autism Spectrum Disorder

Overview
Journal Brain Sci
Publisher MDPI
Date 2023 Jan 21
PMID 36672009
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autism spectrum disorder (ASD), is a neurodevelopmental disorder that is known to have a high degree of heritability. Diagnosis of ASD is difficult because of the high heterogeneity of the clinical symptoms. MicroRNAs (miRNAs) can potentially be diagnostic biomarkers for ASD, and several studies have shown the relationship between miRNAs and ASD pathogenesis. In this study, we investigated ten miRNA and mRNA expression of target genes in peripheral blood to explore a diagnostic biomarker for ASD.

Methods: We recruited control and ASD subjects for the discovery cohort ( = 6, each) and replication cohort ( = 20, each). Using qPCR, miRNA and mRNA expression was measured using the SYBR green and probe methods, respectively. In-silico prediction was used for identifying target genes of miRNAs. An in vitro experiment using HEK293 cells was conducted to investigate whether miR-15b-5p modulates the predicted target genes (TGFBR3 and MYBL1).

Results: miR-15b-5p expression indicated an increased trend in the discovery cohort ( = 0.052) and a significant upregulation in the replication cohort ( = 0.021). In-silico analysis revealed that miR-15b-5p is relevant to cell development and Wnt signaling. The decreased trends of TGFBR3 and MYBL expression were the same as in previous RNA-seq data. MiR-15b-5p positively regulated TGFBR3 expression in in vitro experiments.

Conclusions: Upregulated miR-15b-5p expression may represent a useful diagnostic marker of ASD subjects, and it may regulate TGFBR3 mRNA expression. These findings indicate a new perspective in the understanding of the pathogenesis of ASD.

Citing Articles

Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers.

Martinez B, Peplow P Neural Regen Res. 2024; 20(10):2776-2786.

PMID: 39314171 PMC: 11826456. DOI: 10.4103/NRR.NRR-D-24-00712.


Fetal Brain-Derived Exosomal miRNAs from Maternal Blood: Potential Diagnostic Biomarkers for Fetal Alcohol Spectrum Disorders (FASDs).

Darbinian N, Hampe M, Martirosyan D, Bajwa A, Darbinyan A, Merabova N Int J Mol Sci. 2024; 25(11).

PMID: 38892014 PMC: 11172088. DOI: 10.3390/ijms25115826.


Expression of miRNAs in Pre-Schoolers with Autism Spectrum Disorders Compared with Typically Developing Peers and Its Effects after Probiotic Supplementation.

Guiducci L, Cabiati M, Santocchi E, Prosperi M, Morales M, Muratori F J Clin Med. 2023; 12(22).

PMID: 38002774 PMC: 10672692. DOI: 10.3390/jcm12227162.

References
1.
Swetlik C, Earp S, Franco K . Adults with autism spectrum disorder: Updated considerations for healthcare providers. Cleve Clin J Med. 2019; 86(8):543-553. DOI: 10.3949/ccjm.86a.18100. View

2.
Gaugler T, Klei L, Sanders S, Bodea C, Goldberg A, Lee A . Most genetic risk for autism resides with common variation. Nat Genet. 2014; 46(8):881-5. PMC: 4137411. DOI: 10.1038/ng.3039. View

3.
Somekh J . Model-based pathway enrichment analysis applied to the TGF-beta regulation of autophagy in autism. J Biomed Inform. 2021; 118:103781. DOI: 10.1016/j.jbi.2021.103781. View

4.
Horiuchi F, Yoshino Y, Kumon H, Hosokawa R, Nakachi K, Kawabe K . Identification of aberrant innate and adaptive immunity based on changes in global gene expression in the blood of adults with autism spectrum disorder. J Neuroinflammation. 2021; 18(1):102. PMC: 8086363. DOI: 10.1186/s12974-021-02154-7. View

5.
Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J . Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2010; 25(1):40-5. PMC: 2991432. DOI: 10.1016/j.bbi.2010.08.003. View